Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-24 5:15 pm Purchase |
2023-05-17 | 13G | Elevation Oncology, Inc. ELEV |
Point72 Asset Management, L.P. | 2,121,170 8.700% |
2,121,170 (New Position) |
Filing History |
| 2023-05-16 4:02 pm Purchase |
2023-05-15 | 13G | CUTERA INC CUTRQ |
Point72 Asset Management, L.P. | 1,144,407 5.800% |
1,144,407 (New Position) |
Filing History |
| 2023-04-05 4:23 pm Purchase |
2023-04-04 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 4,533,756 5.000% |
2,095,618 (+85.95%) |
Filing History |
| 2023-03-09 4:17 pm Purchase |
2022-12-31 | 13G | Cepton, Inc. CPTN |
Point72 Asset Management, L.P. | 181,523 1.200% |
181,523 (New Position) |
Filing History |
| 2023-02-23 7:43 pm Purchase |
2023-02-22 | 13G | Inari Medical, Inc. NARI |
Point72 Asset Management, L.P. | 2,795,352 5.200% |
2,795,352 (New Position) |
Filing History |
| 2023-02-17 4:35 pm Purchase |
2023-02-16 | 13G | Iovance Biotherapeutics, Inc. IOVA |
Point72 Asset Management, L.P. | 8,114,890 5.000% |
8,114,890 (New Position) |
Filing History |
| 2023-02-14 4:27 pm Purchase |
2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Point72 Asset Management, L.P. | 3,114,107 6.700% |
1,131,546 (+57.07%) |
Filing History |
| 2023-02-14 4:25 pm Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 3,515,356 7.100% |
116,695 (+3.43%) |
Filing History |
| 2023-02-14 4:23 pm Purchase |
2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Point72 Asset Management, L.P. | 7,702,831 9.200% |
1,094,273 (+16.56%) |
Filing History |
| 2023-02-14 4:23 pm Sale |
2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 193,400 5.400% |
-22,502 (-10.42%) |
Filing History |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
Point72 Asset Management, L.P. | 251,266 6.700% |
64,622 (+34.62%) |
Filing History |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Point72 Asset Management, L.P. | 2,086 5.300% |
2,086 (New Position) |
Filing History |
| 2023-02-14 4:21 pm Sale |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 2,124,200 7.500% |
-157,000 (-6.88%) |
Filing History |
| 2023-02-14 4:20 pm Purchase |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 1,150,648 7.400% |
189,778 (+19.75%) |
Filing History |
| 2023-02-14 4:20 pm Purchase |
2022-12-31 | 13G | Eos Energy Enterprises, Inc. EOSE |
Point72 Asset Management, L.P. | 5,535,030 6.700% |
2,493,265 (+81.97%) |
Filing History |
| 2023-02-14 4:19 pm Sale |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
Point72 Asset Management, L.P. | 69,450 0.100% |
-1,984,767 (-96.62%) |
Filing History |
| 2023-02-14 4:19 pm Sale |
2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
Point72 Asset Management, L.P. | 1,178,501 1.900% |
-1,828,637 (-60.81%) |
Filing History |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | Health Catalyst, Inc. HCAT |
Point72 Asset Management, L.P. | 1,920,253 3.500% |
-864,631 (-31.05%) |
Filing History |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management, L.P. | 30,441 1.300% |
-23,999 (-44.08%) |
Filing History |
| 2023-02-14 4:17 pm Unchanged |
2022-12-31 | 13G | Cepton, Inc. CPTN |
Point72 Asset Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |